In the preceding three months, 10 analysts have released ratings for Encompass Health EHC, presenting a wide array of perspectives from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 4 | 6 | 0 | 0 | 0 |
| Last 30D | 0 | 2 | 0 | 0 | 0 |
| 1M Ago | 1 | 1 | 0 | 0 | 0 |
| 2M Ago | 1 | 1 | 0 | 0 | 0 |
| 3M Ago | 2 | 2 | 0 | 0 | 0 |
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $108.9, with a high estimate of $117.00 and a low estimate of $100.00. This current average reflects an increase of 4.6% from the previous average price target of $104.11.
Interpreting Analyst Ratings: A Closer Look
A comprehensive examination of how financial experts perceive Encompass Health is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Andrew Mok | Barclays | Raises | Overweight | $116.00 | $109.00 |
| Matthew Gillmor | Keybanc | Raises | Overweight | $117.00 | $115.00 |
| David Macdonald | Truist Securities | Raises | Buy | $108.00 | $104.00 |
| Matthew Gillmor | Keybanc | Announces | Overweight | $115.00 | - |
| Ben Hendrix | RBC Capital | Raises | Outperform | $105.00 | $95.00 |
| Andrew Mok | UBS | Raises | Buy | $110.00 | $100.00 |
| David Macdonald | Truist Securities | Raises | Buy | $104.00 | $100.00 |
| Andrew Mok | UBS | Raises | Buy | $100.00 | $96.00 |
| Scott Fidel | Stephens & Co. | Maintains | Overweight | $105.00 | $105.00 |
| Andrew Mok | Barclays | Lowers | Overweight | $109.00 | $113.00 |
Key Insights:
- Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Encompass Health. This information offers a snapshot of how analysts perceive the current state of the company.
- Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Encompass Health compared to the broader market.
- Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Encompass Health's stock. This comparison reveals trends in analysts' expectations over time.
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Encompass Health's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
Stay up to date on Encompass Health analyst ratings.
Discovering Encompass Health: A Closer Look
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas.
Encompass Health: Delving into Financials
Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.
Revenue Growth: Encompass Health displayed positive results in 3 months. As of 30 June, 2024, the company achieved a solid revenue growth rate of approximately 9.61%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Health Care sector.
Net Margin: Encompass Health's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 8.71% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Encompass Health's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 6.33%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Encompass Health's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.8% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Encompass Health's debt-to-equity ratio is below the industry average at 1.6, reflecting a lower dependency on debt financing and a more conservative financial approach.
Understanding the Relevance of Analyst Ratings
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
